Singular Genomics Systems Inc (OMIC) Financials

$20.01

$0.00 (0.00%)

As on 21-Feb-2025 09:30EDT

Market cap

$51 Mln

Revenue (TTM)

$3 Mln

P/E Ratio

--

P/B Ratio

0.4

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Operating Revenue	2.67	2.91	0.77	--	--	--
Cost of Revenue	5.74	3.47	0.79	1.13	0.64	0.35
Gross Profit	-3.08	-0.56	-0.02	-1.13	-0.64	-0.35
Operating Expenses	89.93	102.24	93.46	61.28	27.53	12.77
Operating Profit (EBIT)	-93.00	-102.80	-93.49	-61.28	-27.53	-12.77
Other Income	--	--	2.61	-1.45	--	--
Profit before Tax	-86.32	-94.82	-90.88	-98.77	-27.95	-12.32
Provision for Tax	2.22	9.08	-2.61	0.12	0.72	0.02
Profit after Tax (Net Income)	-86.32	-94.82	-88.27	-98.89	-28.66	-12.34
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	-90.88	-98.77	-27.95	-12.32

Liabilities ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Shareholder's Funds	123.25	179.01	260.32	336.17	-51.56	-24.73
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	45.69	68.17	53.54	12.73	78.37	71.79
Current Liabilities	17.61	18.29	14.12	6.74	3.69	1.11
Total Liabilities	204.16	265.47	327.98	355.65	30.50	48.17

Assets ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Non-Current Assets	56.74	73.24	59.54	7.89	2.93	1.72
Current Assets	129.81	192.23	268.43	347.76	27.57	46.46
Total Assets	204.16	265.47	327.98	355.65	30.50	48.17
Total Debt*	50.49	75.29	58.84	9.90	9.40	2.40
Net Current Assets	112.20	173.94	254.31	341.02	23.88	45.35

Cashflow ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Cash From Operating Activities	--	-73.65	-87.09	-51.70	-24.87	-11.40
Cash Flow from Investing Activities	--	--	-39.57	-130.86	24.01	-31.50
Cash from Financing Activities	--	0.70	0.90	372.13	7.52	47.30
Net Cash Inflow / Outflow	--	--	-125.76	189.57	--	--

Financials Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Adjusted EPS ($)	-34.92	-38.68	-1.23	-1.37	-0.41	--
Cash EPS ($)	--	-35.70	-1.15	-1.35	-0.40	--
Adjusted Book Value ($)	--	73.01	3.64	4.66	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-30.04	-1.22	-0.72	-0.36	--
Free Cash Flow per Share ($)	--	-30.43	-1.30	-0.78	-0.38	--

Profitability Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
ROCE (%)	--	-33.07	-26.54	-65.08	88.90	--
ROE (%)	-61.67	-43.17	-29.60	-69.49	75.15	--
ROA (%)	-34.25	-31.96	-25.82	-51.22	-72.86	--
EBIT Margin (%)	-3,195.01	-3,219.48	-11,779.87	--	--	--
Net Margin (%)	-3,237.88	-3,257.30	-2,616.99	6,834.07	--	--
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Revenue Growth (%)	2.74	2.81	--	--	--	--
EBIT Growth (%)	8.74	-4.00	-46.10	-128.20	-119.62	--
Net Profit Growth (%)	3.83	-7.42	10.74	-245.01	-132.26	--
EPS Growth (%)	-245.68	-30.36	0.10	-2.32	--	--
Book Value Growth (%)	-39.60	--	--	--	--	--

Valuation Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Price / Earnings	--	-0.01	-1.63	-8.44	--	--
Price / Book Value	0.41	0.01	0.55	2.48	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	0.77	1.13	0.50	-8.34	--	--
Close Price ($)	15.67	13.80	60.30	346.80	--	--
High Price ($)	19.80	90.00	366.60	1,001.10	--	--
Low Price ($)	5.34	9.30	54.00	295.20	--	--
Market Cap ($ Cr)	50.77	--	--	--	--	--

Solvency Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Debt to Equity	0.04	0.42	0.23	0.03	-0.18	-0.10
Short term debt to equity ratio	0.04	0.09	0.05	--	-0.02	--
Current Ratio	7.37	10.51	19.01	51.57	7.47	41.78
Quick Ratio	6.67	9.77	17.72	51.12	7.48	--
Interest Coverage	-74.52	-85.12	-118.11	-72.91	-37.64	-723.94

Operating Efficiency Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Debtors to sales (%)	37.92	54.41	263.01	--	--	--
Asset Turnover	0.01	0.01	0.00	--	--	--
Receivable days	--	225.60	730.98	--	--	--
Inventory Days	--	1,673.74	4,914.44	482.59	-9.72	--
Payable days	--	299.34	1,260.78	447.29	282.37	585.44
Cash Conversion Cycle	--	1,600.00	4,384.63	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.